Literature DB >> 16225779

Virulence determinants in Staphylococcus aureus and their involvement in clinical syndromes.

Tristan Ferry1, Thomas Perpoint, François Vandenesch, Jerome Etienne.   

Abstract

Staphylococcus aureus is a major human pathogen responsible for a variety of toxin-mediated and suppurative diseases. About 50 staphylococcal virulence factors have been described to date. In this review, we examine the clinical implications of key staphylococcal virulence factors in toxin-mediated diseases, septic shock, and severe focal infections such as arthritis, infective endocarditis, pneumonia acquired during mechanical ventilation, and necrotizing pneumonia. Staphylococcal pathogenicity is sometimes due principally to a single virulence factor, as in toxic shock syndrome and necrotizing pneumonia. In contrast, several virulence factors are involved in other staphylococcal disease, such as septic shock. A better knowledge of the mechanism of action of each virulence factor involved in the different staphylococcal diseases could open the way to the use of specific inhibitors in the clinical setting.

Entities:  

Year:  2005        PMID: 16225779     DOI: 10.1007/s11908-005-0043-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  51 in total

Review 1.  Toxic shock syndrome and bacterial superantigens: an update.

Authors:  J K McCormick; J M Yarwood; P M Schlievert
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

2.  Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1.

Authors:  Marisa I Gómez; Aram Lee; Bharat Reddy; Amanda Muir; Grace Soong; Allyson Pitt; Ambrose Cheung; Alice Prince
Journal:  Nat Med       Date:  2004-07-11       Impact factor: 53.440

Review 3.  Surface protein adhesins of Staphylococcus aureus.

Authors:  T J Foster; M Höök
Journal:  Trends Microbiol       Date:  1998-12       Impact factor: 17.079

4.  Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis.

Authors:  Christopher Weidenmaier; Andreas Peschel; Yan-Qiong Xiong; Sascha A Kristian; Klaus Dietz; Michael R Yeaman; Arnold S Bayer
Journal:  J Infect Dis       Date:  2005-04-11       Impact factor: 5.226

5.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

Review 6.  Recognition of Staphylococcus aureus by the innate immune system.

Authors:  Bénédicte Fournier; Dana J Philpott
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

7.  Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.

Authors:  John B Robbins; Rachel Schneerson; Gary Horwith; Robert Naso; Ali Fattom
Journal:  Am Heart J       Date:  2004-04       Impact factor: 4.749

8.  Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro.

Authors:  Valérie Gauduchon; Gregoire Cozon; François Vandenesch; Anne-Laure Genestier; Nathalie Eyssade; Simone Peyrol; Jerome Etienne; Gerard Lina
Journal:  J Infect Dis       Date:  2004-01-09       Impact factor: 5.226

9.  Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.

Authors:  Andrea E Hall; Paul J Domanski; Pratiksha R Patel; John H Vernachio; Peter J Syribeys; Elena L Gorovits; Michael A Johnson; Julia M Ross; Jeff T Hutchins; Joseph M Patti
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units.

Authors:  C Brun-Buisson; P Meshaka; P Pinton; B Vallet
Journal:  Intensive Care Med       Date:  2004-03-02       Impact factor: 17.440

View more
  28 in total

1.  Evaluation of the Activity of a Combination of Three Bacteriophages Alone or in Association with Antibiotics on Staphylococcus aureus Embedded in Biofilm or Internalized in Osteoblasts.

Authors:  Camille Kolenda; Jérôme Josse; Mathieu Medina; Cindy Fevre; Sébastien Lustig; Tristan Ferry; Frédéric Laurent
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 2.  The challenge of infection prevention in spine surgery: an update.

Authors:  T Ferry; F Valour; S Lustig; F Laurent; G Perrin; C Chidiac; C Barrey
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-05-21

3.  Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue.

Authors:  Lisa Marie Schlecht; Brian M Peters; Bastiaan P Krom; Jeffrey A Freiberg; Gertrud M Hänsch; Scott G Filler; Mary Ann Jabra-Rizk; Mark E Shirtliff
Journal:  Microbiology       Date:  2014-10-20       Impact factor: 2.777

4.  Differences in humoral immune response between patients with or without nasal carriage of Staphylococcus aureus.

Authors:  H Ghasemzadeh-Moghaddam; W van Wamel; A van Belkum; R A Hamat; V K Neela
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-04       Impact factor: 3.267

5.  Exoproteome of Staphylococcus aureus reveals putative determinants of nasal carriage.

Authors:  Gowrishankar Muthukrishnan; Gerry A Quinn; Ryan P Lamers; Carolyn Diaz; Amy L Cole; Sixue Chen; Alexander M Cole
Journal:  J Proteome Res       Date:  2011-03-07       Impact factor: 4.466

6.  Antimicrobial activity against intraosteoblastic Staphylococcus aureus.

Authors:  Florent Valour; Sophie Trouillet-Assant; Natacha Riffard; Jason Tasse; Sacha Flammier; Jean-Philippe Rasigade; Christian Chidiac; François Vandenesch; Tristan Ferry; Frédéric Laurent
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

7.  Clonal complexes and diversity of exotoxin gene profiles in methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from patients in a Spanish hospital.

Authors:  M A Argudín; M C Mendoza; F J Méndez; M C Martín; B Guerra; M R Rodicio
Journal:  J Clin Microbiol       Date:  2009-05-20       Impact factor: 5.948

8.  Identification of factors contributing to T-cell toxicity of Staphylococcus aureus clinical isolates.

Authors:  James Collins; Angus Buckling; Ruth C Massey
Journal:  J Clin Microbiol       Date:  2008-04-16       Impact factor: 5.948

9.  Comparison of adhesion and virulence of two predominant hospital-acquired methicillin-resistant Staphylococcus aureus clones and clonal methicillin-susceptible S. aureus isolates.

Authors:  Hatice Karauzum; Tristan Ferry; Sophie de Bentzmann; Gérard Lina; Michèle Bes; François Vandenesch; Mathias Schmaler; Brigitte Berger-Bächi; Jerome Etienne; Regine Landmann
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

10.  Staphylococcus aureus Ventilator-Associated Pneumonia: A Study of Bacterio-Epidemiological Profile and Virulence Factors.

Authors:  Lamia Tilouche; Refka Ben Dhia; Sameh Boughattas; Soumaya Ketata; Olfa Bouallegue; Cherifa Chaouch; Noureddine Boujaafar
Journal:  Curr Microbiol       Date:  2021-05-10       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.